TY - JOUR
T1 - Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus
T2 - data from a multi-ethnic, multinational Latin American lupus cohort
AU - Quintana, Rosana
AU - Pons-Estel, Guillermo J.
AU - Roberts, Karen
AU - Sacnún, Mónica
AU - Serrano, Rosa
AU - Nieto, Romina
AU - Conti, Silvana
AU - Gervasoni, Viviana
AU - Catoggio, Luis J.
AU - Soriano, Enrique R.
AU - Scolnik, Marina
AU - García, Mercedes A.
AU - Alvarellos, Alejandro
AU - Saurit, Verónica
AU - Berbotto, Guillermo A.
AU - Sato, Emilia I.
AU - Costallat, Lilian T.Lavras
AU - Neto, Eduardo Ferreira Borba
AU - Bonfa, Eloisa
AU - Xavier, Ricardo M.
AU - de Oliveira e Silva Montandon, Ana Carolina
AU - Molina-Restrepo, José Fernando
AU - Iglesias-Gamarra, Antonio
AU - Guibert-Toledano, Marlene
AU - Reyes-Llerena, Gil Alberto
AU - Massardo, Loreto
AU - Neira, Oscar J.
AU - Cardiel, Mario H.
AU - Barile-Fabris, Leonor A.
AU - Amigo, Mary Carmen
AU - Silveira, Luis H.
AU - Torre, Ignacio García De La
AU - Acevedo-Vásquez, Eduardo M.
AU - Ugarte-Gil, Manuel F.
AU - Alfaro-Lozano, José Luis
AU - Segami, María Inés
AU - Chacón-Díaz, Rosa
AU - Esteva-Spinetti, María H.
AU - Gomez-Puerta, José A.
AU - Alarcón, Graciela S.
AU - Pons-Estel, Bernardo A.
N1 - Publisher Copyright:
© The Author(s) 2020.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Objectives: This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods: A multi-ethnic, multinational Latin American SLE cohort was studied. Familial lupus was defined as patients with a first-degree SLE relative; these relatives were interviewed in person or by telephone. Clinical variables, disease activity, damage, and mortality were compared. Odds ratios (OR) and 95% confidence intervals (CI) were estimated. Hazard ratios (HR) were calculated using Cox proportional hazard adjusted for potential confounders for time to damage and mortality. Results: A total of 66 (5.6%) patients had familial lupus, and 1110 (94.4%) had sporadic lupus. Both groups were predominantly female, of comparable age, and of similar ethnic distribution. Discoid lupus (OR = 1.97; 95% CI 1.08–3.60) and neurologic disorder (OR = 1.65; 95% CI 1.00–2.73) were significantly associated with familial SLE; pericarditis was negatively associated (OR = 0.35; 95% CI 0.14–0.87). The SLE Disease Activity Index and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were similar in both groups, although the neuropsychiatric (45.4% vs. 33.5%; p = 0.04) and musculoskeletal (6.1% vs. 1.9%; p = 0.02) domains of the SDI were more frequent in familial lupus. They were not retained in the Cox models (by domains). Familial lupus was not significantly associated with damage accrual (HR = 0.69; 95% CI 0.30–1.55) or mortality (HR = 1.23; 95% CI 0.26–4.81). Conclusion: Familial SLE is not characterized by a more severe form of disease than sporadic lupus. We also observed that familial SLE has a higher frequency of discoid lupus and neurologic manifestations and a lower frequency of pericarditis.
AB - Objectives: This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods: A multi-ethnic, multinational Latin American SLE cohort was studied. Familial lupus was defined as patients with a first-degree SLE relative; these relatives were interviewed in person or by telephone. Clinical variables, disease activity, damage, and mortality were compared. Odds ratios (OR) and 95% confidence intervals (CI) were estimated. Hazard ratios (HR) were calculated using Cox proportional hazard adjusted for potential confounders for time to damage and mortality. Results: A total of 66 (5.6%) patients had familial lupus, and 1110 (94.4%) had sporadic lupus. Both groups were predominantly female, of comparable age, and of similar ethnic distribution. Discoid lupus (OR = 1.97; 95% CI 1.08–3.60) and neurologic disorder (OR = 1.65; 95% CI 1.00–2.73) were significantly associated with familial SLE; pericarditis was negatively associated (OR = 0.35; 95% CI 0.14–0.87). The SLE Disease Activity Index and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were similar in both groups, although the neuropsychiatric (45.4% vs. 33.5%; p = 0.04) and musculoskeletal (6.1% vs. 1.9%; p = 0.02) domains of the SDI were more frequent in familial lupus. They were not retained in the Cox models (by domains). Familial lupus was not significantly associated with damage accrual (HR = 0.69; 95% CI 0.30–1.55) or mortality (HR = 1.23; 95% CI 0.26–4.81). Conclusion: Familial SLE is not characterized by a more severe form of disease than sporadic lupus. We also observed that familial SLE has a higher frequency of discoid lupus and neurologic manifestations and a lower frequency of pericarditis.
KW - Systemic lupus erythematosus
KW - damage accrual
KW - disease activity
KW - familial lupus
KW - mortality
KW - sporadic lupus
UR - http://www.scopus.com/inward/record.url?scp=85087318875&partnerID=8YFLogxK
U2 - 10.1177/0961203320935184
DO - 10.1177/0961203320935184
M3 - Article
C2 - 32605527
AN - SCOPUS:85087318875
SN - 0961-2033
VL - 29
SP - 1140
EP - 1145
JO - Lupus
JF - Lupus
IS - 9
ER -